led to extensive decomposition. Fortunately, a method
developed by Mulliez to form peptide-derived trioxopipera-
zines proved successful.23 Thus, when a solution of 15 and
1,1,1,3,3,3-hexamethyldisilazane was heated at 140 °C in a
sealed tube, cyclization to form the trioxopiperazine and
elimination of the methoxy group both took place to give
(+)-gliocladin C (1), a pale yellow solid, in 73% yield.
Comparison of 1H and 13C NMR data24,25 of synthetic 1 with
those of the natural product confirmed their identity. The
optical rotation of synthetic 1, [R]23D +116 (c 0.02 CHCl3),
compared well with that reported for the natural sample, [R]D
+131 (c 0.07 CHCl3). Because the relative and absolute
configuration of the Fmoc derivative of synthetic precursor
7 had been determined by single-crystal X-ray analysis,9 this
comparison establishes the absolute configuration of (+)-
gliocladin C (1) to be as depicted.
Scheme 2. Construction of the Trioxopiperazine Ring To
Form (+)-Gliocladin C (1)
In summary, the first total synthesis of the structurally
novel marine alkaloid (+)-gliocladin C (1) was completed
in ∼4% overall yield and 21 steps from isatin. A central
step in this sequence is asymmetric construction of the
quaternary carbon stereocenter by a Mukaiyama aldol
reaction of siloxyindole 4 and enantiopure aldehyde 5.9
Knowledge gained during the latter stages of this synthesis
could potentially allow the synthetic sequence to be stream-
lined. Of more importance, a better appreciation of the acid
sensitivity of pyrrolidinoindolines containing oxygen sub-
stituents at C3 should assist in the design of synthetic
approaches to related, more complex, and biologically more
potent alkaloids.26
Acknowledgment. This research was supported by Grant
No. GM-30859 from the National Institutes of General
Medical Sciences. We also thank Amgen, Merck, Pfizer, and
Roche Palo Alto for unrestricted support. We particularly
thank Professor Y. Usami (Osaka University of Pharmaceuti-
cal Sciences) for providing copies of NMR spectra of natural
gliocladin C and for useful discussions. We also thank Dr.
Young Ho Rhee for optimizing the synthesis of 7 and Dr.
Se´bastien Caille´ for first preparing compounds 8 and 9. NMR
and mass spectra were determined at UC Irvine with
instruments purchased with the assistance of the NSF and
NIH shared instrumentation programs.
hydroxymethylpyrrolidinoindoline 11. To set the stage for
assembling the trioxopiperazine ring, the Boc group was
cleaved by reaction of 12 with TMSI to give secondary amine
13 in 65% yield.19,20 A preliminary survey of the reactivity
of the pyrrolidine nitrogen of congeners of 1321 had shown
that acylation of the hindered and inductively deactivated
secondary amine was problematic; thus, the benzyl protecting
group of the adjacent nitrogen and that of the indole
substituent were removed at this stage by the reaction of 13
at -78 °C with excess Na and t-BuOH in THF-NH3. This
deprotection was remarkably clean, providing the secondary
triamine 14 in 87% yield. Although several potential ap-
proaches for fashioning the trioxopiperazine ring in one step
were unsuccessful,22 reaction of 14 with ethyl chlorooxo-
acetate in the presence of Et3N took place cleanly at N5 to
give oxalyl half-ester half-amide 15 in 87% yield. To our
initial dismay, attempts to cyclize this intermdiate by reaction
with a variety of bases (e.g., DBU, i-Pr2EtN, Et3N, or NaH)
Supporting Information Available: Experimental pro-
1
cedures, tabulated H and 13C NMR spectra of natural and
1
synthetic (+)-gliocladin C, copies of H and 13C NMR
spectra of new compounds, and the X-ray model of the C3
acetate analogue of 13. This material is available free of
OL062801Y
(17) (a) Bal, B. S.; Childers, W. E., Jr.; Pinnick, H. W. Tetrahedron
1981, 37, 2091-2096. (b) Kraus, G. A.; Taschner, M. J. J. Org. Chem.
1980, 45, 1175-1176.
(23) Mulliez, M.; Royer, J. Tetrahedron 1984, 40, 5143-5151.
(24) The small signal for the quaternary carbon C3′ at 116.7 ppm, which
is seen in the 13C NMR spectrum of natural gliocladin C, was not reported
in ref 2. Assignments reported in this paper for signals at 122.7 and 120.11/
120.13 ppm should be changed to C6′ and C4′/C5′.25 A summary of peak
assignments for synthetic gliocladin C, which were established by HMQC
and HMBC experiments, can be found in the Supporting Information.
(25) Usami, Y. Personal communication, Aug 8, 2006.
(18) BOP ) benzotriazole-1-yloxy-tris(dimethylamino)phosphonium
hexafluorophosphate.
(19) Depew, K. M.; Marsden, S. P.; Zatorska, D.; Zatorski, A.; Bornmann,
W. G.; Danishefsky, S. J. J. Am. Chem. Soc. 1999, 121, 11953-11963.
(20) The C3 acetate analogue of 13 provided single crystals allowing
the relative configuration of this intermediate to be confirmed by X-ray
crystallography.
(21) The substituent was OAc or OTIPS instead of OMe.
(22) (a) Makino, S.; Nakanishi, E.; Tsuji, T. Synlett 2003, 6, 817-820.
(b) Bailey, P. D.; Bannister, N.; Bernad, M.; Blanchard, S.; Boa, A. N. J.
Chem. Soc., Perkin Trans. 1 2001, 3245-3251.
(26) Anthoni, U.; Christophersen, C.; Nielsen, P. H. Naturally Occurring
Cyclotryptophans and Cyclotryptamines. In Alkaloids: Chemical and
Biological PerspectiVes; Pelletier, S. W., Ed.; Pergamon: New York, 1999;
Vol. 13, pp 163-236.
Org. Lett., Vol. 9, No. 2, 2007
341